Bridgebio Pharma Inc
BBIO
$44.515+0.14 (+0.30%)
Jun 26, 2025, 12:36 PM
Financials
| 52Week High | 45.18 | 52Week Low | 21.62 |
| Beta | 1.19 | Current Ratio Annual | 4.67 |
| Current Ratio Quarterly | 4.57 | Gross Margin TTM | 95.35 |
| Market Cap | 8.40B | Net Profit Margin TTM | -524.25 |
| Operating Margin TTM | -424.22 | Price To Book | 145.12 |
| Price To Sales TTM | 65.94 | Quick Ratio Annual | 4.44 |
| Quick Ratio Quarterly | 4.31 | Return On Assets TTM | -81.95 |
| Return On Equity TTM | -206.74 | Return On Investment TTM | -65.34 |
| Revenue Growth3Y | 47.10 | Revenue Growth5Y | 40.48 |
| Revenue Growth Quarterly Yoy | -44.76 | Revenue Growth TTMYoy | -41.71 |
| Revenue Per Share TTM | 0.67 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 271 | 2 | 1 | 7 | 7 | 1 | 192.08M | $5.22B |
| Mar 31, 2025 | 307 | 69 | 33 | 117 | 84 | 29 | 200.02M | $6.81B |
| Change | 36(13%) | 67(3350%) | 32(3200%) | 110(1571%) | 77(1100%) | 28(2800%) | 7.94M(4%) | $1.58B(30%) |